Correction: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Phase II evaluation of zanubrutinib plus R-CHOP for untreated diffuse large B-cell lymphoma with a specific gene alteration

  • By

  • Qunling Zhang

  • Shiyu Jiang

  • Ran Wei

  • Wenhao Zhang

  • Longlong Bao

  • Yizhen Liu

  • Jia Jin

  • Fangfang Lv

  • Chuanxu Liu

  • Xiaojian Liu

  • Hui Sun

  • Jiachen Wang

  • Rong Tao

  • Xiaoyan Zhou

  • Junning Cao

  • November 5, 2026

Share

Original Source(s)

Correction: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study

  • by Qunling Zhang, Shiyu Jiang, Ran Wei, Wenhao Zhang, Longlong Bao, Yizhen Liu, Jia Jin, Fangfang Lv, Chuanxu Liu, Xiaojian Liu, Hui Sun, Jiachen Wang, Rong Tao, Xiaoyan Zhou, Junning Cao

  • November 5, 2026

Related Content

Two ‘forever chemicals’ associated with higher risk of aggressive breast cancer in NIH analysis

  • November 5, 2026

Roswell Park is a Center of Excellence for Rectal Cancer Surgery

Roswell Park Comprehensive Cancer Center is a nationally accredited and certified Center of Excellence for colorectal cancer surgery due to the high volume of procedures completed annually for patients with colon and rectal cancer.

  • October 27, 2026

  • 2 min
Beyond the LARS score: functional burden does not necessarily equal psychological burden